| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.004 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.09 | 0.004 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.004 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.004 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.21 | 0.005 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.13 | 0.005 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.11 | 0.006 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.006 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.097 | 0.006 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.006 |